Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
16.75
+0.06 (0.36%)
At close: Jan 16, 2026, 4:00 PM EST
16.53
-0.22 (-1.31%)
After-hours: Jan 16, 2026, 5:40 PM EST
Bicara Therapeutics Analyst Ratings
Total Analysts
7
Consensus Rating
Buy
Price Target
$25.14
Upside
+50.09%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Reiterates $30 | Buy | Reiterates | $30 | +79.10% | Jan 13, 2026 |
| BTIG | BTIG | Strong Buy Initiates $28 | Strong Buy | Initiates | $28 | +67.16% | Jan 8, 2026 |
| Mizuho | Mizuho | Hold Initiates $18 | Hold | Initiates | $18 | +7.46% | Dec 18, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $8 → $11 | Hold | Maintains | $8 → $11 | -34.33% | Nov 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $41 → $40 | Strong Buy | Maintains | $41 → $40 | +138.81% | Aug 22, 2025 |
| Piper Sandler | Piper Sandler | Buy Initiates $36 | Buy | Initiates | $36 | +114.93% | Aug 19, 2025 |
| Wells Fargo | Wells Fargo | Sell → Hold Upgrades $8 | Sell → Hold | Upgrades | $8 | -52.24% | May 23, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $44 → $41 | Strong Buy | Maintains | $44 → $41 | +144.78% | May 16, 2025 |
| Wells Fargo | Wells Fargo | Sell Initiates $8 | Sell | Initiates | $8 | -52.24% | Apr 17, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $45 → $44 | Strong Buy | Maintains | $45 → $44 | +162.69% | Apr 7, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $13 | Buy | Reiterates | $13 | -22.33% | Mar 13, 2025 |
| Wedbush | Wedbush | Buy Reiterates $31 | Buy | Reiterates | $31 | +85.07% | Feb 12, 2025 |
| Wedbush | Wedbush | Buy Initiates $31 | Buy | Initiates | $31 | +85.07% | Feb 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $42 → $45 | Strong Buy | Maintains | $42 → $45 | +168.66% | Jan 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $42 | Strong Buy | Initiates | $42 | +150.75% | Dec 6, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Oct 8, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.